Inmaculada Peiró

685 total citations
23 papers, 390 citations indexed

About

Inmaculada Peiró is a scholar working on Physiology, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Inmaculada Peiró has authored 23 papers receiving a total of 390 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Physiology, 8 papers in Oncology and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Inmaculada Peiró's work include Nutrition and Health in Aging (10 papers), Neuroendocrine Tumor Research Advances (5 papers) and Neuroblastoma Research and Treatments (4 papers). Inmaculada Peiró is often cited by papers focused on Nutrition and Health in Aging (10 papers), Neuroendocrine Tumor Research Advances (5 papers) and Neuroblastoma Research and Treatments (4 papers). Inmaculada Peiró collaborates with scholars based in Spain, France and Canada. Inmaculada Peiró's co-authors include Lorena Arribas, Ernest Nadal, Ricard Mesı́a, Alicia Lozano, N. Virgili, Francisco Javier Martínez-Martín, Miren Taberna, Silvia Vázquez, Ramón Palmero and Pedro Iglesias and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and European Journal of Clinical Nutrition.

In The Last Decade

Inmaculada Peiró

19 papers receiving 377 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Inmaculada Peiró Spain 11 153 142 91 67 55 23 390
Rocío Villar‐Taibo Spain 12 146 1.0× 37 0.3× 33 0.4× 20 0.3× 40 0.7× 39 382
Karin J.C. Sanders Netherlands 8 191 1.2× 51 0.4× 133 1.5× 14 0.2× 67 1.2× 15 317
Alisdair J. MacDonald United Kingdom 12 425 2.8× 103 0.7× 204 2.2× 10 0.1× 82 1.5× 17 790
S. Joglekar United States 4 312 2.0× 116 0.8× 53 0.6× 12 0.2× 149 2.7× 4 387
Annalisa Mascheroni Italy 4 215 1.4× 81 0.6× 34 0.4× 12 0.2× 82 1.5× 5 291
Aldo Alberto Beneduce Italy 4 293 1.9× 370 2.6× 266 2.9× 9 0.1× 23 0.4× 5 781
María Dolors Muns Spain 7 199 1.3× 48 0.3× 30 0.3× 4 0.1× 81 1.5× 9 276
Sinéad King Ireland 11 213 1.4× 100 0.7× 293 3.2× 7 0.1× 93 1.7× 21 609
L Monnier France 10 43 0.3× 29 0.2× 48 0.5× 19 0.3× 2 0.0× 38 347

Countries citing papers authored by Inmaculada Peiró

Since Specialization
Citations

This map shows the geographic impact of Inmaculada Peiró's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inmaculada Peiró with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inmaculada Peiró more than expected).

Fields of papers citing papers by Inmaculada Peiró

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inmaculada Peiró. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inmaculada Peiró. The network helps show where Inmaculada Peiró may publish in the future.

Co-authorship network of co-authors of Inmaculada Peiró

This figure shows the co-authorship network connecting the top 25 collaborators of Inmaculada Peiró. A scholar is included among the top collaborators of Inmaculada Peiró based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inmaculada Peiró. Inmaculada Peiró is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Guerrero‐Pérez, Fernando, Inmaculada Peiró, J.L. Vercher-Conejero, Àlex Teulé, & Carles Villabona. (2024). Carcinoid crisis: The challenge is still there. Endocrinología Diabetes y Nutrición (English ed ). 71(6). 263–270.
3.
Pernas, Sònia, Raül Rigo‐Bonnin, Àlex Teulé, et al.. (2024). Everolimus Through Plasmatic Concentrations in Cancer Patients: Prospective Longitudinal Observational Multicentric Study (DIANA-1 Project). Journal of Clinical Medicine. 14(1). 145–145. 1 indexed citations
4.
Pacheco-Barcía, Vilma, Alberto Carmona‐Bayonas, Javier Gállego, et al.. (2024). Nutritional impact and prognostic role of systemic inflammatory response index (SIRI) in advanced pancreatic cancer: PANTHEIA-Spanish Society of Medical Oncology (SEOM) study results.. Journal of Clinical Oncology. 42(3_suppl). 623–623. 1 indexed citations
5.
Guerrero‐Pérez, Fernando, Inmaculada Peiró, J.L. Vercher-Conejero, Àlex Teulé, & Carles Villabona. (2024). Carcinoid crisis: The challenge is still there. Endocrinología Diabetes y Nutrición. 71(6). 263–270.
6.
Arribas, Lorena, A. Sabaté-Llobera, Miren Taberna, et al.. (2021). Adequacy of nutritional support using computed tomography (CT) in patients with head and neck cancer (HNC) during chemo-radiotherapy (CRT). European Journal of Clinical Nutrition. 75(10). 1515–1519. 6 indexed citations
7.
Guerrero‐Pérez, Fernando, Inmaculada Peiró, Àlex Teulé, et al.. (2021). Ectopic Cushing’s syndrome due to thymic neuroendocrine tumours: a systematic review. Reviews in Endocrine and Metabolic Disorders. 22(4). 1041–1056. 10 indexed citations
8.
Arribas, Lorena, et al.. (2021). Nutriscore is now validated for oncohematological inpatients: nutriscore_h. Clinical Nutrition ESPEN. 46. S714–S714. 1 indexed citations
9.
Peiró, Inmaculada, Ramón Palmero, Pedro Iglesias, et al.. (2019). Thyroid dysfunction induced by nivolumab: searching for disease patterns and outcomes. Endocrine. 64(3). 605–613. 50 indexed citations
10.
Rullan, Antonio, Maria Saigí, Inmaculada Peiró, et al.. (2019). Fasting plasma glucose is an independent predictor of survival in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy. BMC Cancer. 19(1). 165–165. 26 indexed citations
11.
Simó-Servat, Andreu, Inmaculada Peiró, & Carles Villabona. (2018). Tumor neuroendocrino pancreático secretor de corticotropina, un reto en el manejo terapéutico. A propósito de 2 casos. Endocrinología Diabetes y Nutrición. 66(3). 204–206. 2 indexed citations
12.
Ramos, Ricard, Ernest Nadal, Inmaculada Peiró, et al.. (2018). Preoperative nutritional status assessment predicts postoperative outcomes in patients with surgically resected non-small cell lung cancer. European Journal of Surgical Oncology. 44(9). 1419–1424. 41 indexed citations
13.
Marín, Mar, Carlota Gudiol, Florian Castet, et al.. (2018). Bloodstream infection in patients with head and neck cancer: a major challenge in the cetuximab era. Clinical & Translational Oncology. 21(2). 187–196. 13 indexed citations
14.
Carmona‐Bayonas, Alberto, et al.. (2017). Supportive care in pancreatic ductal adenocarcinoma. Clinical & Translational Oncology. 19(11). 1293–1302. 17 indexed citations
15.
Arribas, Lorena, Miren Taberna, Inmaculada Peiró, et al.. (2017). Nutritional changes in patients with locally advanced head and neck cancer during treatment. Oral Oncology. 71. 67–74. 56 indexed citations
16.
Arribas, Lorena, et al.. (2016). Interacción entre tratamientos oncológicos y soporte nutricional. Nutrición Hospitalaria. 33(1). 179–179. 3 indexed citations
17.
Arribas, Lorena, et al.. (2016). NUTRISCORE: A new nutritional screening tool for oncological outpatients. Nutrition. 33. 297–303. 68 indexed citations
18.
Arribas, Lorena, et al.. (2014). [Predict factors associated with malnutrition from patient generated subjective global assessment (PG-SGA) in head and neck cancer patients].. SHILAP Revista de lepidopterología. 28(1). 155–63. 18 indexed citations
19.
Martínez-Martín, Francisco Javier, et al.. (2010). Olmesartan/amlodipine vs olmesartan/hydrochlorothiazide in hypertensive patients with metabolic syndrome: the OLAS study. Journal of Human Hypertension. 25(6). 346–353. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026